EPISODE · Oct 21, 2022 · 33 MIN
Clinical Trials and Post-Market Side Effects
from Experts InSight
Drs. Sarah Read, M. Ali Khan, and Ajay Kuriyan join a group discussion on incorporating newly approved medications into practice, focusing on real-world examples of Vuity (pilocarpine drops), brolucizumab, and drugs for dry AMD in trial. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Embed this episode
NOW PLAYING
Clinical Trials and Post-Market Side Effects
0:00
33:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Experts InSight?
This episode is 33 minutes long.
When was this Experts InSight episode published?
This episode was published on October 21, 2022.
Can I download this Experts InSight episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!